Article date: January 2008
The National Patient Safety Agency (NPSA) is alerting all healthcare professionals who use oral anticancer medicines about potentially fatal outcomes if incorrect doses are prescribed, dispensed, or administered. Risks are increased if healthcare practitioners who are not cancer specialists prescribe, dispense, or administer these medicines.
NPSA is issuing guidance to all clinical staff that the prescribing, dispensing, and administering of oral anticancer medicine should be carried out and monitored to the same standard as that for injected cancer therapy.
Article citation: Drug Safety Update Jan 2008: Vol 1, Issue 6: 10
Published 11 December 2014